Asher Khan

Management of Treatment Complications and Supportive Care

F. Buadi, Asher Khan, 2010 .

The use of onabotulinumtoxinA to treat idiopathic overactive bladder in elderly patients is in need of study

A. Wagg, K. Carlson, Asher Khan, 2021, Neurourology and urodynamics.

Targeting the microenvironment: a new treatment paradigm for chronic lymphocytic leukaemia

Asher Khan, 2006 .

The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells

S. Pierrou, S. Linder, P. D'Arcy, 2016, Scientific Reports.

Malignant Melanoma Presenting as Spinal Cord and Pleural Lesions

A. Farhan, Asher Khan, Aysha Albastaki, 2023, Case reports in oncological medicine.

The relationship between overactive bladder and prostate cancer: A scoping review.

R. Crump, K. Carlson, Asher Khan, 2021, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Corrigendum: The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells

S. Pierrou, S. Linder, J. Gullbo, 2016, Scientific Reports.

Baseline patient reported outcomes data shows high prevalence of overactive bladder, sexual dysfunction, depression and anxiety in Canadian men with newly diagnosed localized prostate cancer

R. Crump, K. Carlson, Asher Khan, 2020, Translational andrology and urology.